| Regulatory
Matters |
| |
Acetaminophen
(Paracetamol INN) prescription products |
| |
Benzonatate |
| |
Bevacizumab |
| |
Bisphosphonate |
| |
Dextropropoxyphene |
| |
Dolasetron
mesylate |
| |
Dronedarone |
| |
Insulin
combined with pioglitazone |
| |
Quinine |
| |
Saquinavir |
| |
Sibutramine |
| |
Sitaxentan |
|
Safety of Medicines |
| |
Carbapenem |
| |
Clozapine |
| |
Codeine |
| |
Non-steroidal
anti-inflammatory drugs |
| |
Somatropin |
| Feature |
| |
Inspection
of Manufacturing Sites for Active Pharmaceutical |
| |
Ingredients
within the WHO Prequalification of Medicines Programme |
| |
Meeting
of the Global Advisory Committee on Vaccine Safety (GACVS) |